Researcher
Wee-Wei Tee received his PhD in stem cell biology under Azim Surani at the University of Cambridge, UK. He pursued postdoctoral research in the lab of Danny Reinberg at HHMI-NYU School of Medicine, focusing on epigenetic gene silencing mechanisms. Tee received several awards including the New York Stem Cell Foundation Druckenmiller Fellowship and the NIH Pathway to Independence (K99/R00) Award. In 2016, he was granted the Singapore National Research Foundation (NRF) Fellowship, establishing his independent research. Currently, he’s a Principal Investigator at A*STAR’s Institute of Molecular and Cell Biology (IMCB) and an Assistant Professor at the NUS Yong Loo Lin School of Medicine. In 2022, he was selected as an EMBO Global Investigator. His lab studies epigenetic regulation in early mammalian development and cancer cell phenotypic plasticity.
Related Articles
Baring breast cancer’s genetic dependencies
2 Jan 2024Researchers reveal how disrupting a key genetic control mechanism can significantly hinder the progression and
Unlocking the full potential of stem cells
20 Apr 2020Modifying how embryonic stem cells use sugar can switch them into a totipotent state, A*STAR



